Overview of Innovation
Science Corporation, founded by Max Hodak, is making strides in brain-computer technology. The company aims to develop a biohybrid interface that blends living neurons with electronics. This initiative is set to enter human trials, led by Dr. Murat Günel from Yale Medical School. The first sensor will be implanted in a patient’s brain, marking a significant step in neuroscience.
Key Details
- Dr. Günel has joined as a scientific adviser after extensive discussions, focusing on surgical implantation of the first sensor.
- Science recently completed a $230 million Series C funding round, valuing the company at $1.5 billion.
- The company’s leading product, PRIMA, aims to restore vision for those with blindness due to macular degeneration.
- Unlike traditional methods, the new device will rest on top of the brain rather than penetrate it, reducing risks associated with surgery.
Significance of the Development
This advancement could revolutionize treatments for various neurological conditions. If successful, the biohybrid system may not only aid in healing but also enhance communication between the brain and technology. This could lead to better management of diseases like Parkinson’s, offering hope where current treatments fall short. The integration of biological and electronic systems presents a new frontier in medicine, potentially improving the quality of life for countless patients.
